886
COVID-19 IN A PATIENT WITH CHRONIC LYMPHOCYTIC LEUKEMIA IN USE OF IBRUTINIB: NOT THAT RISKY?
M.L.B.F. Dourado, V.B.A.S. Eira, G. Matias, O.C.C.G. Baiocchi
Universidade Federal de São Paulo (UNIFESP), São Paulo, SP, Brazil
Lido
2426
Vezesque se leu este artigo
1078
Total PDF
1348
Total HTML
| Ano/Mês | Html | Total | |
|---|---|---|---|
| 2025 6 | 11 | 12 | 23 |
| 2025 5 | 42 | 10 | 52 |
| 2025 4 | 44 | 18 | 62 |
| 2025 3 | 58 | 10 | 68 |
| 2025 2 | 39 | 19 | 58 |
| 2025 1 | 36 | 22 | 58 |
| 2024 12 | 33 | 15 | 48 |
| 2024 11 | 36 | 21 | 57 |
| 2024 10 | 30 | 18 | 48 |
| 2024 9 | 32 | 14 | 46 |
| 2024 8 | 28 | 18 | 46 |
| 2024 7 | 22 | 19 | 41 |
| 2024 6 | 26 | 18 | 44 |
| 2024 5 | 35 | 18 | 53 |
| 2024 4 | 30 | 18 | 48 |
| 2024 3 | 26 | 16 | 42 |
| 2024 2 | 33 | 26 | 59 |
| 2024 1 | 28 | 24 | 52 |
| 2023 12 | 18 | 20 | 38 |
| 2023 11 | 42 | 25 | 67 |
| 2023 10 | 26 | 31 | 57 |
| 2023 9 | 27 | 30 | 57 |
| 2023 8 | 19 | 11 | 30 |
| 2023 7 | 32 | 11 | 43 |
| 2023 6 | 36 | 16 | 52 |
| 2023 5 | 28 | 13 | 41 |
| 2023 4 | 14 | 3 | 17 |
| 2023 3 | 22 | 13 | 35 |
| 2023 2 | 22 | 12 | 34 |
| 2023 1 | 23 | 10 | 33 |
| 2022 12 | 23 | 13 | 36 |
| 2022 11 | 25 | 21 | 46 |
| 2022 10 | 28 | 25 | 53 |
| 2022 9 | 26 | 21 | 47 |
| 2022 8 | 14 | 23 | 37 |
| 2022 7 | 20 | 26 | 46 |
| 2022 6 | 17 | 17 | 34 |
| 2022 5 | 20 | 16 | 36 |
| 2022 4 | 17 | 34 | 51 |
| 2022 3 | 17 | 15 | 32 |
| 2022 2 | 13 | 23 | 36 |
| 2021 1 | 15 | 15 | 30 |
| 2021 12 | 11 | 20 | 31 |
| 2021 11 | 12 | 20 | 32 |
| 2021 10 | 13 | 29 | 42 |
| 2021 9 | 19 | 35 | 54 |
| 2021 8 | 19 | 26 | 45 |
| 2021 7 | 19 | 19 | 38 |
| 2021 6 | 16 | 21 | 37 |
| 2021 5 | 13 | 37 | 50 |
| 2021 4 | 34 | 31 | 65 |
| 2021 3 | 14 | 22 | 36 |
| 2021 2 | 15 | 11 | 26 |
| 2020 1 | 7 | 12 | 19 |
| 2020 12 | 6 | 19 | 25 |
| 2020 11 | 17 | 16 | 33 |
Mostrar tudo
